APM Stock Summary and Trading Ideas (Aptorum Group Limited - Class A | NASDAQ:APM)

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group Limited - Class A trades on the NASDAQ stock market under the symbol APM.

As of December 31, 2024, APM stock price climbed to $2.80 with 79,923,128 million shares trading.

APM has a beta of 1.37, meaning it tends to be more sensitive to market movements. APM has a correlation of 0.01 to the broad based SPY ETF.

APM has a market cap of $15.32 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, APM traded as high as $23.50 and as low as $.46.

The top ETF exchange traded funds that APM belongs to (by Net Assets): ONEQ.

APM has underperformed the market in the last year with a return of +14.4%, while SPY returned +24.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in APM shares. However, APM has outperformed the market in the last 3 month and 2 week periods, returning +55.6% and +264.8%, while SPY returned +2.5% and -2.7%, respectively. This indicates APM has been having a stronger performance recently.

APM support price is $1.18 and resistance is $1.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APM shares will trade within this expected range on the day.